Member Info for Mancave

We still have the potential for news from AZ, Japan, etc. These could come at any time.

"In addition and as previously announced, the Company has 164,817,352 warrants in issue, exercisable on or before the 9 April 2019, to subscribe for Ordinary Shares at a price of 6.57" So in 12 months we should expect the SP to be quite a bit higher?

What we need now is news on interest from Japan in the next day or so and we will be flying....!

Moring all - somebody mentioned that they had emailed NIgel a few days ago. Was there any response?

Last good bit of news was on a Friday, out of the blue (pardon the pun)...... Could we see a repeat?

Does Nigel respond to PI emails? I have experienced some stocks where PI/company interaction is sparse to say the least.

Thanks apple

Dr B/Chartist - not whining about LSE - just curious as to why no trades shown Thanks for the update Chartist.

No trades: 19 Shares sold: 0 Shares bought: 0 WTF?

And we are nearly two months in to the Medimmune collaboration.......... I wonder if and when AZ are going to bid for exclusivity if the evaluation is proving successful

Thanks C2/Andy - would be nice to see our faith rewarded

C2 - do you think there could be trend reversal this PM or will only news force a new trend?

Taking kids to Lanza end of May - cannot wait!!!

Sorry - wrong board!!!!!!!

"Under the Disposal, Sound Energy would agree to dispose of 100 per cent. of the issued ordinary share capital of SEHIL, the Company's wholly owned subsidiary which holds all of the Company's Italian Interests through APN, but would retain its economic rights to receive the proceeds of the sale of Badile land owned by APN (the "Badile Land"), which had an unaudited carrying value of �1.6 million as at 30 June 2017, and the benefit of expected APN Italian VAT receivables to the end of 2017 totalling EUR4.0 million linked to Badile drilling costs (the "VAT"). Under the Disposal, Saffron would undertake to remit the net proceeds of the Badile Land and the VAT to Sound Energy on receipt by APN. " When does SOU receive this money? Surely it would assist with funding or has it already been factored in? Genuine question.

Woul Nigels holding not be reduced due to the amount of warrants being converted? Or has he actually sold?

Don't forget Sildenafil: BDD operate a phase 1 clinical trials unit based in Glasgow Royal Infirmary and are specialists in conducting clinical studies for investigational medicinal products. The Pilot Trial is due to take place in early 2018 with results expected by the end of April 2018. Only 6-7 weeks away.....

Thanks for the clarification Hugh - always learning.....

Exactly, maybe this RNS was also a shot across the bows that exclusivity is time limited.

Extract from the RNS: "Recently, N4 Pharma announced a partnership with MedImmuneUK and is looking to add additional partnerships in due course." Would AZ want this to happen - cant see them wanting additional partners....... Answers on a postcard please.